Researchers at the University of Exeter have developed a new approach to studying potentially deadly disease-causing bacteria which could help speed up the process of finding vaccines.
Dr. Andrea Dowling, from the Centre for Ecology and Conservation at the university's Cornwall Campus, has pioneered a simple screen which can help isolate the virulent parts of the gene structures of pathogenic bacteria. The screen allows researchers to simultaneously run thousands of tests where genes from the pathogen are pitted against the human blood cells that normally attack them.
"By looking at the results from these tests it is possible to determine which parts of a pathogen's genetic code allow it to override immune systems," says Dowling. "From there we can focus in on those key areas to find out how the pathogen works and how we can develop vaccines. The screen allows us to study and tackle the causes of disease and infection much quicker than other methods."
The screen has been used by Dowling and other researchers at Exeter to look at genes in the important pathogen, Burkholderia pseudomallei, which causes the potentially deadly human disease, melioidosis. The research is published in the journal, PLoS ONE.
Burkholderia appears to be able to infect man directly from the environment via cuts and grazes. Normally any invading bacteria would be consumed by the body's immune system, but Burkholderia bacteria seem to resist being eaten and can spread to other parts of the body in a very nasty infection.
Using the screen, the researchers were able to isolate the unique parts of Burkholderia's genetic code which could be responsible for its resistance to the human immune system.
Dowling explains, "We used library-clones which each contain a genetic region of Burkholderia, and then studied each one's ability to kill immune cells to find what are known as virulence factors basically the parts which allow it to override the immune system. Using the screen, we established the potential locations of that virulence factor much quicker than using normal methods.
"We can then study the mechanism for these factors using microbiological, cellular and biochemical techniques to see whether disrupting the virulence factor reduces the abilities of this bacteria to overcome the immune system."
Professor Richard Ffrench-Constant, a co-author of the research, says, "Knowledge gained from this research provides essential insights into how this poorly understood, but extremely serious human pathogen works to cause disease, and, crucially, it helps us identify candidates for the development of much needed vaccines."
The techniques used for this research are not only important in looking at Burkholderia, but can also be used on many other pathogens.
This work was supported by Biotechnology and Biological Sciences Research Council (BBSRC) and N.R.W., and by the European Community Seventh Framework Programme.
The Next Frontier in Infection Control: AI-Driven Operating Rooms
Published: July 15th 2025 | Updated: July 15th 2025Discover how AI-powered sensors, smart surveillance, and advanced analytics are revolutionizing infection prevention in the OR. Herman DeBoard, PhD, discusses how these technologies safeguard sterile fields, reduce SSIs, and help hospitals balance operational efficiency with patient safety.
Targeting Uncertainty: Why Pregnancy May Be the Best Time to Build Vaccine Confidence
July 15th 2025New national survey data reveal high uncertainty among pregnant individuals—especially first-time parents—about vaccinating their future children, underscoring the value of proactive engagement to strengthen infection prevention.
CDC Urges Vigilance: New Recommendations for Monitoring and Testing H5N1 Exposures
July 11th 2025With avian influenza A(H5N1) infections surfacing in both animals and humans, the CDC has issued updated guidance calling for aggressive monitoring and targeted testing to contain the virus and protect public health.
IP LifeLine: Layoffs and the Evolving Job Market Landscape for Infection Preventionists
July 11th 2025Infection preventionists, once hailed as indispensable during the pandemic, now face a sobering reality: budget pressures, hiring freezes, and layoffs are reshaping the field, leaving many IPs worried about their future and questioning their value within health care organizations.